Clinical Trials Browser

Phase 1 × OTHER × (177)Lu-DOTA-EB-TATE × Clear all

NCT03478358 2022-08-31

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase 1 Unknown

Neuroendocrine Tumors

NCT03308682 2017-10-12

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase 1 Unknown

Neuroendocrine Tumors